<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209271</url>
  </required_header>
  <id_info>
    <org_study_id>EPN 2016/986-31/1</org_study_id>
    <nct_id>NCT03209271</nct_id>
  </id_info>
  <brief_title>Hemodynamic Effects of Cold Versus Warm Fluid Bolus</brief_title>
  <official_title>Hemodynamic Effects of Cold Versus Warm Fluid Bolus Infusion in Healthy Volunteers: a Randomized Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid boluses are often administered with the aim of improving tissue perfusion in critically
      ill patients. It is unclear whether the temperature of the fluid has an impact on the
      hemodynamic response. The aim of this study is to describe the hemodynamic effects of a fluid
      bolus with two different temperatures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, controlled, cross-over study in 21 healthy volunteers. The participants will
      receive a fluid bolus of 500 ml Ringer's Acetate at either 22°C or 38°C over 15 minutes in a
      randomized order. Non-invasive measures will be made of cardiac index, mean arterial
      pressure, systolic blood pressure, diastolic blood pressure, heart and pulse rate, saturation
      and temperature. Hemodynamic measure will be made using the Clearsight® system. Measurements
      will be made during 120 minutes. The second session will take place at least one day later,
      and the participant will then receive the other fluid temperature.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 3, 2017</start_date>
  <completion_date type="Actual">May 27, 2017</completion_date>
  <primary_completion_date type="Actual">May 27, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover study of 2 different temperatures of crystalloid fluid bolus.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Unblinded (unable to blind subjects)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac index 15 minutes</measure>
    <time_frame>15 minutes</time_frame>
    <description>Change in cardiac index at 15 minutes from start of infusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac index 120 minutes</measure>
    <time_frame>120 minutes</time_frame>
    <description>Change in cardiac index during 120 minutes from start of infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure 120 minutes</measure>
    <time_frame>120 minutes</time_frame>
    <description>Change in blood pressure during 120 minutes from start of infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate 120 minutes</measure>
    <time_frame>120 minutes</time_frame>
    <description>Change in heart rate during 120 minutes from start of infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature 120 minutes</measure>
    <time_frame>120 minutes</time_frame>
    <description>Change in body temperature during 120 minutes from start of infusion</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to return to baseline for CI</measure>
    <time_frame>0-120 minutes</time_frame>
    <description>Time to return to baseline for CI</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to return to baseline for blood pressure</measure>
    <time_frame>0-120 minutes</time_frame>
    <description>Time to return to baseline for blood pressure</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to return to baseline for heart rate</measure>
    <time_frame>0-120 minutes</time_frame>
    <description>Time to return to baseline for heart rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to return to baseline for temperature</measure>
    <time_frame>0-120 minutes</time_frame>
    <description>Time to return to baseline for temperature</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Temperature Change, Body</condition>
  <condition>Hypovolemia</condition>
  <arm_group>
    <arm_group_label>Body temperature fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>500ml Ringers Acetate infused over 15 minutes warmed to 38°C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room temperature fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500ml Ringers Acetate infused over 15 minutes cooled to 22°C</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's Acetate (warm)</intervention_name>
    <description>Body temperature fluid</description>
    <arm_group_label>Body temperature fluid</arm_group_label>
    <other_name>Ringer-Acetat Baxter Viaflo, ATC B05BB01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's Acetate (cold)</intervention_name>
    <description>Room temperature fluid</description>
    <arm_group_label>Room temperature fluid</arm_group_label>
    <other_name>Ringer-Acetat Baxter Viaflo, ATC B05BB01</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Volunteers 18 years or older Previously healthy

        Exclusion Criteria:

          -  American Society of Anesthesiologists classification 2 or above.

          -  Known pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Cronhjort, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska Institutet Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christer Svensen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fluid therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
    <mesh_term>Body Temperature Changes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

